Jump to Main Content

Newsroom

Submit
Reset

ASH Statement on Executive Order to Suspend Work Visas

Jun 24
2020

Latest restriction on immigration will harm health care workforce, curtail medical research and practice, and hinder economic recovery (WASHINGTON, June 24, 2020) — President Trump recently signed an executive order suspending immigration visas...

Read more

ASH Announces 2020 Honorific Award Recipients

Jun 23
2020

(WASHINGTON, June 23, 2020) — The American Society of Hematology (ASH) congratulates this year’s recipients of the Honorific Awards, the Society’s most prestigious awards which recognize hematologists who have made significant contr...

Read more

ASH Releases New Clinical Practice Guidelines on Management of Pain in Sickle Cell Disease

Jun 19
2020

Pain guideline is the latest in Society’s evidence-based series of clinical practice guidelines for sickle cell disease aiming to improve and personalize care for individuals with this complex condition (WASHINGTON, June 19, 2020) – Toda...

Read more

PerkinElmer and ASH Announce Global Collaboration to Help Combat Sickle Cell Disease

Jun 18
2020

Initiative to enhance newborn screening in underserved populations for improved health outcomes in Africa WALTHAM, Mass. – June 18, 2020 – PerkinElmer, Inc. (NYSE:PKI), a global leader committed to innovating for a healthier world, today announced a...

Read more

Message from the ASH President on Diversity, Equity, and Inclusion

Jun 09
2020

As doctors, we understand the power of diverse perspectives to accelerate science and improve care. As professionals, we know that opportunities are not distributed equally within our field. As healers, we seek to dismantle disparities in health and...

Read more

For Acute Myeloid Leukemia, Genetic Testing Is Often Worth the Wait

Jun 08
2020

Study suggests treatment delay does not increase risks and offers a window for selection of more personalized therapy (WASHINGTON, June 4, 2020) — New tailored therapies offer exciting prospects for treating acute myeloid leukemia (AML), but ta...

Read more

Early Treatment Linked to Reduced Joint Damage in Young Adults with Severe Hemophilia A

Jun 03
2020

Initiation of intravenous Factor VIII treatment in early childhood improves joint outcomes in young adulthood (WASHINGTON, June 3, 2020) — Children with severe hemophilia A who receive early prophylaxis are less likely to have joint damage in y...

Read more

ASH/ASH RC/CMSS Statement on Racism in Healthcare

Jun 01
2020

The American Society of Hematology and ASH Research Collaborative stand in unity with the Council of Medicine Specialty Societies (CMSS) and the 800,000 physicians across 45 medical specialties that deplore the negative impact of racism in our nation...

Read more

ASH Research Collaborative COVID-19 Registry for Hematologic Malignancy Reaches Milestone of 100 Patient Cases

May 13
2020

(WASHINGTON, May 13, 2020) — The ASH Research Collaborative (ASH RC) COVID-19 Registry for Hematologic Malignancy has reached the critical milestone of surpassing its first 100 clinical cases submitted. The ASH RC COVID-19 Registry, a global p...

Read more

ASH to Develop Clinical Practice Guidelines on the Use of Anticoagulation in Patients with COVID-19

May 12
2020

Society will convene panel of experts to make evidence-based recommendations to address blood clotting among COVID-19 patients (WASHINGTON, May 12, 2020) — Coagulopathy, or abnormal blood clotting, has been reported as a complication associated...

Read more